English Version

About Mario Penna

The history of Mario Penna Institute, named after the tireless physician who became pioneer in the treatment of cancer in Minas Gerais, begins in 1963, in a wing at Hospital Borges da Costa, which was dedicated exclusively to patients in terminal stages of the disease.

Back then, the State government prepared a shed in Santa Efigênia where these people should be taken, but the scenario was pretty cruel: due to the deplorable condition of helplessness and lack of assistance, the place was known as a “deposit”.
In 1971, thanks to the intensive work of volunteers who embraced the cause, the “Association of Friends of Hospital Mario Penna” was born. The group has managed to achieve a number of improvements for the patients in the former “deposit”, in which the main goal was to return the human dignity in the treatment of the terminally ill – something that should never have been lost in the first place.

Nowadays, Mario Pena Institute continues to fight cancer throughout the support of the society, including hospitals that are highly regarded for this kind of treatment such as Hospital Mario Penna, Hospital Luxemburgo and Casa de Apoio Beatriz Ferraz.

MPI also has a Teaching and Research Center for the discovery of treatments, diagnoses and better understanding of cancer.
Mario Penna Institute is responsible for meeting 70% of new cases of cancer in Belo Horizonte and its metropolitan area and more than 20% of new cases of the disease in the entire state of Minas Gerais.

Hospital Luxemburgo

Inaugurated in 1986, Hospital Luxemburgo is one of Mario Penna Intitute’s units. It assists patients from both private health insurances and public care. The hospital is a reference in oncology in the state and in the country.
Also, Hospital Luxemburgo is one of three health institutions in the state classified by the Ministry of Health as a Center for High Complexity in Oncology (CACON, in Portuguese). In 2016, it performed more than 1 million procedures in the most diverse specialties.

The facility offers infrastructure based in high technology to receive patients and caregivers: there are 258 beds, CTIs, a Bone Marrow Transplantation Unit, an Intensive Coronary Unit, a Surgical Center, Diagnostic Services, a complete Hemodynamics, Nuclear Medicine, Endoscopy Central, an Anatomy Laboratory, a Pathological Clinic, a 24/7 ER, Chemotherapy and Radiation Therapy, and also Consultancy Services, in addition to magnetic resonance imaging equipment, ultrasound, mammography, colonoscopy, endoscopy, linear accelerators, CT scans and surgical rooms for video-guided procedures.
Hospital Luxemburgo has an experienced and specialized clinical staff. Alongside the assistive team, they offer patients and their families a high quality and humanized treatment.

Medical Specialties

Urology, Orthopedics, Interventional Neurology, Neurosurgery, Mastology, Clinical Pain Gynecology, Vascular Surgery, Thoracic Surgery, Plastic Surgery, Oncology Surgery, General Surgery, Cardiac Surgery, Head and Neck Surgery, Interventional Cardiology, Anesthesiology, Radiotherapy, Pneumology, Nutrology, Neurology, Nephrology, Hematology, Gastroenterology, Endocrinology, Dermatology, Clinical Medicine, Cardiology and Clinical Oncology.

Medical Services

Intensive Cardiology Unit, Computed Tomography Ultrasonography, Social Work, Magnetic Nuclear Resonance, Radiotherapy, Simple and Contrast Radiography, Chemotherapy, Psychology, 24-hour Care, Mammography, Humanization, Haemotherapy and Blood Bank, Hemodynamics, Speech Therapy, Physiotherapy, Multidisciplinary Team (Digestive Endoscopy, Echocardiogram), Duplex Scan, Commission for the Prevention and Treatment of Skin Lesions, Intensive Care Center, Biopsy guided by US, Biopsy guided by Tomography and Psychological Assistance.

Hospital Mario Penna

Hospital Mario Penna was inaugurated in 1971 with the emergence of the Association of Friends of Hospital Mario Penna in Belo Horizonte. The initiative is the result of the group’s vision: to bring dignity and better treatments to cancer patients in terminal condition.

This hospital was Mario Penna Institute’s activities kickstarter.

Nowadays the Hospital is one of the four units of the Institute, and is totally geared towards treating cancer patients from poor families through the Brazilian public Unified Health System (SUS). It has 58 beds for hospitalization, ambulatory, chemotherapy service, radiology, clinical analysis laboratory, operating rooms and intermediate care unit.
It is accurate to say that Hospital Mario Penna performs, annually, more than 260 thousand oncological procedures and about 45 thousand consultations, in adition to 15 thousand chemotherapy sessions. To achieve these numbers with excellence, the hospital counts on an interdisciplinary team formed by experienced and qualified clinical staff members who offers to patients and their companions a high quality and humanized treatment.

Beatriz Ferraz House of Support

Beatriz Ferraz House of Support was inaugurated in 2006 from the merge of Célia Janotti Home (for adults and elderly) and Januário Carneiro Home (for children and teens). The House of Support currently has the capacity to host 42 simultaneous guests.

The House of Support takes care of adult cancer patients from the Brazilian public Unified Health System (SUS) who come from other locations in Minas Gerais and cannot afford to pay for their housing and food while in treatment.

The House offers, for free, the hosting, three meals a day, psychological feeding service, 24-hours care staff, leisure activities, library, rest room, toy library and transport for care in Mario Penna Institute’s hospitals. In addition, the pain is softened by the attention, protection, care and support given by employees and volunteers through a lodging that offers comfort and dignity.

Center of Education and Research

Inaugurated in 2014 with the main objective of contributing to technological innovation at the service of cancer patients, the Center of Education and Research (NEP, in Portuguese) is the unit of the Mário Penna Institute responsible for the development of research on new technologies that impact on prevention, diagnosis, treatment and monitoring of cancer.
The Center has a sophisticated system of equipment for genetic and cellular analysis of cancer, as well as a biorepository consisting of human biological material collected and stored throughout the execution of a research project.
Defined as a key element in the strategic planning of Mario Penna Institute, the research activity, through this Center, involves a multidisciplinary professional body that includes members of the clinical staff who work in the research and production of data, generating knowledge and advances in the field of oncology.
The research fronts are diverse within the Mario Penna Institute. They cover treatment areas, nursing care, genetics, infection, nutrition, physiotherapy, occupational therapy, imaging, surgery and supportive therapies.
The Center carries out translational and clinical research activities, develops projects related to epidemiology, diagnosis and treatment that meet the oncological profile of Mario Penna Institute.

Publications and Research

ASSESMENT OF THE VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN MORPHOLOGICALLY NORMAL APPENDICES REMOVED FROM PATIENTS WITH CLINICAL DIAGNOSIS OF ACUTE APPENDICITIS
Barroso TVV, Sales PGO, Petroianu A (2015) Assesment of the Vasoactive Intestinal Polypeptide (VIP) in Morphologically Normal Appendices Removed from Patients with Clinical Diagnosis of Acute Appendicitis. Emerg Med (Los Angel) 5:256. doi:10.4172/2165-7548.1000256

EXPRESSION OF PCA3 AND PSA GENES AS A BIOMARKER FOR DIFFERENTIAL DIAGNOSIS OF NODULAR HYPERPLASIA AND PROSTATE CANCER
Coelho FF, Guimarães FL, Cabral WL, Salles PG, Mateo EC, Nogueira e Nogueira
LM, Fonseca CE, Gomes KB. Expression of PCA3 and PSA genes as a biomarker for
differential diagnosis of nodular hyperplasia and prostate cancer. Genet Mol Res.
2015 Oct 28;14(4):13519-31. doi: 10.4238/2015.October.28.13. PubMed PMID:
26535666.

PROCALCITONIN-GUIDED PROTOCOL IS NOT USEFUL TO MANAGE ANTIBIOTIC THERAPY IN FEBRILE NEUTROPENIA: A RANDOMIZED CONTROLLED TRIAL
HN, Melo AC, Salomão LC, Serufo JC. Procalcitonin-guided protocol is not useful
to manage antibiotic therapy in febrile neutropenia: a randomized controlled
trial. Ann Hematol. 2016 Jun;95(7):1169-76. doi: 10.1007/s00277-016-2639-5. Epub
2016 Apr 27. PubMed PMID: 27118539.

Location

INSTITUTO MÁRIO PENNA
Rua Joaquim Cândido Filho, 91 – Luxemburgo
CEP 30380-420 • Belo Horizonte / Minas Gerais – Brazil
Contact: 55 31 3330 9100

HOSPITAL LUXEMBURGO
Rua Gentios, 1350 – Luxemburgo
CEP 30380-490 • Belo Horizonte / Minas Gerais – Brazil
Contact: 55 31 3299 9000

HOSPITAL MÁRIO PENNA
Avenida Churchill, 230 – Santa Efigênia
CEP 30260-080 • Belo Horizonte / Minas Gerais – Brazil
Contact: 55 31 3489 6600

NÚCLEO DE ENSINO E PESQUISA (Center of Education and Research)
Rua Gentios, 1420, 3º andar – Luxemburgo
CEP 30380-472 • Belo Horizonte / Minas Gerais – Brazil

CASA DE APOIO BEATRIZ FERRAZ (Beatriz Ferraz House of Support)
Rua Paraisópolis, 887 – Santa Teresa
CEP 31010-330 • Belo Horizonte / Minas Gerais – Brazil
Contact: 55 31 3465 9350